Figure Gallery

Expression Pattern Search Results for EGFP

(5349 figures with expression from 2299 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Qi et al., 2010	Fig. 1	zf282Et	standard conditions	Protruding-mouth to Day 4	brain liver
Ragvin et al., 2010	Fig. 2	bi105aTg (AB/TU) bi106Tg (AB/TU) bi107Tg (AB/TU) bi108Tg (AB/TU) bi109Tg (AB/TU) bi110Tg (AB/TU)	standard conditions	Long-pec to Protruding-mouth	hindbrain notochord pancreas pronephric duct rhombomere swim bladder bud
Reed et al., 2010	Fig. 5	vu404Tg	standard conditions	Protruding-mouth to Day 4	ceratohyal cartilage perichondrium hypobranchial cartilage perichondrium pharyngeal arch
Ren et al., 2010	Fig. 7	y1Tg y1Tg + MO1-gipc1	standard conditions control chemical treatment: pharmaceutical chemical treatment: pharmaceutical	Prim-25	axial blood vessel caudal vein plexus dorsal aorta dorsal longitudinal anastomotic vessel intersegmental vessel post-vent vasculature angiogenic sprout
Rikin et al., 2010	Fig. 8	twu34Tg twu34Tg + MO1-mgaa twu34Tg + MO1-gata4 + MO1-mgaa	standard conditions standard conditions standard conditions	Protruding-mouth to Day 5	heart
	Fig. 4	twu34Tg twu34Tg + MO1-mgaa	standard conditions standard conditions	Prim-5 to Day 5	heart heart tube
Robert-Moreno et al., 2010	Fig. 1	upo1Tg upo3Tg	standard conditions	1-4 somites to Prim-5	midbrain hindbrain boundary otic region otic vesicle
	Fig. 2	upo1Tg upo3Tg	standard conditions	Prim-5 to Protruding-mouth	anterior crista anterior macula auditory epithelial support cell hair cell lateral crista macula posterior crista posterior macula
	Fig. 3	upo1Tg upo3Tg	control chemical treatment by environment: 4-(diethylamino)benzaldehyde chemical treatment: SU5402 chemical treatment: DAPT chemical treatment: dorsomorphin chemical treatment: Cyclopamine	14-19 somites to Prim-25	otic vesicle
	Fig. 5	upo1Tg	standard conditions	5-9 somites to 14-19 somites	otic region otic vesicle
	Fig. 4	upo2Tg	control chemical treatment: Cyclopamine	Day 4	otic vesicle
Santoriello et al., 2010	Fig. 1	hzm1Et; u300Tg hzm1Et; io006Tg	standard conditions	Protruding-mouth	melanocyte
	Fig. 2	hzm1Et; io006Tg	standard conditions	Adult	head
	Fig. 3	hzm1Et; io006Tg	standard conditions	Adult	unspecified
Schneider et al., 2010	Fig. 3	pt6Tg pt6Tg + MO3-nkd1	standard conditions standard conditions	75%-epiboly to 5-9 somites	forerunner cell group Kupffer's vesicle
Sood et al., 2010	Fig. 2	la2Tg runx1^hg1/hg1; la2Tg	standard conditions	Day 6	thrombocyte ventral wall of dorsal aorta hematopoietic stem cell
Soza-Ried et al., 2010	Fig. 3	fr101Tg myb^{t25127/t25127}; fr101Tg	standard conditions	Prim-5	blood island intermediate cell mass of mesoderm macrophage
	Fig. 4	fr101Tg	standard conditions	Pec-fin	thymus primordium hematopoietic multipotent progenitor cell
Swanhart et al., 2010	Fig. 1	pt303Tg/pt303Tg	standard conditions	Shield to 10-13 somites	diencephalon intermediate mesoderm margin neural keel notochord polster presumptive diencephalon shield
	Fig. 2	pt303Tg/pt303Tg	standard conditions	Prim-5 to Protruding-mouth	anterior lateral line ganglion forebrain hindbrain midbrain otic vesicle posterior lateral line ganglion pronephric duct spinal cord
	Fig. 4	pt303Tg/pt303Tg	standard conditions chemical treatment: dimethyl sulfoxide	Shield	margin shield
Talbot et al., 2010	Fig. 8	trps1^j1271aGt (AB)	standard conditions	Day 4	pharyngeal arch joint splanchnocranium
Teh et al., 2010	Fig. 3	sqet33mi3AEt; sqKR15Et sqet33mi84Et; sqKR15Et sqet33mi103Et; sqKR15Et	standard conditions	Long-pec to Protruding-mouth	endocardium myocardium
	Fig. 4	sqet33mi3AEt; sqKR15Et	lighting conditions, high light intensity	Protruding-mouth	heart
	Fig. 5	sqet33mi3AEt; sqKR15Et	lighting conditions, high light intensity	Protruding-mouth	heart